Expression of Parkin isoforms in human lymphomonocyte by Maugeri, Grazia et al.
IJAE 
Vo l .  120 ,  n .  1  (Supp lem ent) :  175,  2015
© 2015 Firenze University Press 
ht tp://www.fupress .com/ijae
ITALIAN JOURNAL OF ANATOMY AND EMBRYOLOGY
Expression of Parkin isoforms in human 
lymphomonocyte 
Grazia Maugeri1, Valentina La Cognata2, Soraya Scuderi3, Sebastiano Cavallaro2, Velia D’Agata1
1 Department of Biomedical and Biotechnological Sciences, Section of Human Anatomy and Histology,, University 
of Catania, Catania, Italy - 2 Institute of Neurological Sciences, Italian National Research Council, Catania, Italy - 
3 Yale Child Study Center, Yale School of Medicine, New Haven, USA
Parkin (PARK2) is one of the largest gene in the human genome. Its mutations 
cause a form of autosomal recessive juvenile-onset of Parkinson disease (ARJPD) (1). 
To date, a repertoire of 21 parkin alternative splice variants has been identified. In 
the past, the role of the full-length parkin protein was extensively investigated and 
assessed also in human blood samples (2, 3). In contrast, less attention has been put 
on the other isoforms. 
In the present study, we investigated for the first time, the expression profile of 
parkin isoforms in three lymphomonocyte (LMN) subpopulations: T lymphocyte 
(CD2+), monocyte (CD14+) and B lymphocyte (CD19+). 
The expression of H1/H5 and H6 isoforms has been observed in total LMN 
homogenate, whereas H20 and H1/H5 variants were detected in all three LMN sub-
populations by western blot analysis. The cellular distribution of parkin isoforms has 
been evaluated by immunofluorescence analysis. Although parkin is predominantly 
expressed in the cytoplasm, immunoreactivity has also been detected at nuclear and 
perinuclear level.
Our data suggest that, the discovery of a specific expression profile of these iso-
forms into LMN of ARJP patients might allow developing new diagnostic tools for 
this neurodegenerative disease.
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